Advertisement

One Anastomosis Gastric Bypass/Minigastric Bypass in Patients with BMI < 35 kg/m2 and Type 2 Diabetes Mellitus: Preliminary Report

  • Salvador Navarrete AulestiaEmail author
  • José Luis Leyba
  • Salvador Navarrete Llopis
  • Viviana Pulgar
Original Contributions
  • 17 Downloads

Abstract

Introduction

Obesity in the world has been increasing, and the number of diabetic patients will increase by 114%, and the best treatment results are achieved through surgery. Several techniques have been described; the gastric bypass of an anastomosis (MGB/OAGB) has been gaining popularity for its simplicity and good results. We present a prospective study with this technique in 16 mild obesity patients with type 2 diabetes mellitus or peripheral insulin resistance.

Objective

To evaluate weight loss as well as metabolic changes by measuring fasting glycemia and Hb A1c after 1 year of follow-up.

Material and Methods

Sixteen patients were operated on with the OAGB/MGB technique from September 2014 to January 2016, with some form of metabolic syndrome, whether DM2, RPI, HBP, or dyslipidemia, including patients in the study with a follow-up of at least 12 months.

Results

There were 13 cases of female sex and 3 of male, average age of 42.9 years, with an average weight of 87.7 kg and BMI of 32.2 kg/m2. Metabolic values were fasting glycemia of 193.6 ± 52.9 mg/dl and HbA1c of 8.4% ± 1 (preop) and glycemia posop, 78.8 ± 7.6 mg/dl; HbA1c posop, 6.1 ± 0.2; preop weight, 87.7 ± 14 kg (69–116); weight posop, 66.8 ± 10.5 kg (49–90); BMI preop, 32.2 ± 1.8 (30–34.9); BMI posop, 25.4 ± 1.7 (21.7–27.6); percentage of excess weight lost, 87.6 ± 11.8 (70.9–100) % with 100% remission of diabetes.

Conclusion

The results show the benefits of MGB/OAGB in mild obese diabetic patients.

Keywords

Gastric bypass One anastomosis gastric bypass Diabetes mellitus Metabolic surgery Laparoscopy 

Notes

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflict of interest.

Ethical Approval

Approval from the local ethics committee and informed consent from all patients were obtained. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

References

  1. 1.
    Wild S, Relic G, Green SR, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–52.CrossRefGoogle Scholar
  2. 2.
    Adams TD, Grass RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357:753–76.CrossRefGoogle Scholar
  3. 3.
    Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292(14):1724–37.CrossRefGoogle Scholar
  4. 4.
    De Paula AL, Macedo AL, Rassi N, et al. Laparoscopic treatment of type 2 diabetes mellitus for patients with a body mass index < 35 kg/m2. Surg Endosc. 2008;22:706–16.CrossRefGoogle Scholar
  5. 5.
    Shah SS, Todkar JS, Shah PS, et al. Diabetes remission and reduced cardiovascular risk after gastric bypass in Asian Indians with body mass index < 35 kg/m2. Surg Obes Relat Dis. 2010;6:332–8.CrossRefGoogle Scholar
  6. 6.
    De Sa VC, Ferraz AA, Campos J, et al. Gastric bypass in the treatment of type 2 diabetes in patients with a BMI of 30 to 35 kg/m2. Obes Surg. 2011;21:283–7.CrossRefGoogle Scholar
  7. 7.
    Boza C, Muñoz R, Salinas J, et al. Safety and efficacy of Roux-en-Y gastric bypass to treat type 2 diabetes mellitus in non-severely obese patients. Obes Surg. 2011;21:1330–6.CrossRefGoogle Scholar
  8. 8.
    Fried M, Ribaric G, Buchwald JN, et al. Metabolic surgery for the treatment of type 2 diabetes in patients with BMI < 35 kg/m2: an integrative review of early studies. Obes Surg. 2010;20:776–90.CrossRefGoogle Scholar
  9. 9.
    Navarrete SA, Leyba JL, Llopis SN. Laparoscopic sleeve gastrectomy with duodenojejunal bypass for the treatment of type 2 diabetes in non-obese patients: technique and preliminary results. Obes Surg. 2011;21(5):663–7.CrossRefGoogle Scholar
  10. 10.
    Scopinaro N, Adami G, Papadia F, et al. The effects of biliopancreatic diversion on type 2 diabetes mellitus with mild obesity (BMI 30–35 Kg/m2) and simply overweight (BMI 25–30 Kg/m2): a prospective controlled study. Obes Surg. 2011;21(7):880–8.CrossRefGoogle Scholar
  11. 11.
    Rutledge R, Walsh T. Continued excellent results with the mini-gastric bypass: six-year study in 2.410 patients. Obes Surg. 2005;15(9):1304–8.CrossRefGoogle Scholar
  12. 12.
    Carbajo M, Luque-de-León E, Jiménez J, et al. Laparoscopic one-anastomosis gastric bypass: technique, results, and long-term follow-up in 1200 patients. Obes Surg. 2017;27(5):1153–67.CrossRefGoogle Scholar
  13. 13.
    Lee WJ, Lin YH. Single-anastomosis gastric bypass (SAGB): appraisal of clinical evidence. Obes Surg. 2014;24:1749–56.CrossRefGoogle Scholar
  14. 14.
    Garcia-Caballero M, Reyes-Ortiz A, Garcia M, et al. Changes of body composition in patients with BMI 23-50 after tailored one anastomosis gastric bypass (BAGUA): influence of diabetes and metabolic syndrome. Obes Surg. 2014;24:2040–7.CrossRefGoogle Scholar
  15. 15.
    Garcia-Caballero M, Valle M, Martinez-Moreno JM, et al. Resolution of diabetes mellitus and metabolic syndrome in normal weight 24-29 BMI patients with one anastomosis gastric bypass. Nutr Hosp. 2012;27:623–31.Google Scholar
  16. 16.
    Garcia-Caballero M, Martínez-Moreno JM, Tovar JA, et al. Improvement of C-peptide zero BMI 24–34 diabetic patients after tailored one anastomosis gastric bypass (BAGUA). Nutr Hosp. 2013;28(Supl. 2):35–46.Google Scholar
  17. 17.
    Kim MJ, Hur KY. Laparoscopic mini-gastric bypass for type 2 diabetes: the preliminary report. World J Surg. 2011;35:631–6.CrossRefGoogle Scholar
  18. 18.
    Carbajo M, Garcia-Caballero M, Toledano M, et al. One-anastomosis gastric bypass by laparoscopy: results of the first 209 patients. Obes Surg. 2005;15:398–404.CrossRefGoogle Scholar
  19. 19.
    Rutledge R. The mini-gastric bypass: experience with the first 1,274 cases. Obes Surg. 2001;11:276–80.CrossRefGoogle Scholar
  20. 20.
    Schauer P, Kashyap S, Wolski K, et al. Bariatric surgery vs. intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366:1567–76.CrossRefGoogle Scholar
  21. 21.
    ASMBS Clinical Issues Committee. Bariatric surgery in class Iobesity (BMI 30–35 kg/m2). Surg Obes Relat Dis. 2013;9:e1–e10.CrossRefGoogle Scholar
  22. 22.
    Bucetto L, Dixon J, De Luca M, et al. Bariatric surgery in class I obesity, a position statement from the International Federation for the Surgery of Obesity and Metabolic Disrorders (IFSO). Obes Surg. 2014;24(4):487–519.CrossRefGoogle Scholar
  23. 23.
    Dixon JB, Zimmet P, Alberti KG, et al. Bariatric surgery: an IDF statement for obese type 2 diabetes. Diabet Med. 2011 Jun;28(6):628–42.CrossRefGoogle Scholar
  24. 24.
    Rubioa M, Monereoa S, Lecubea A, et al. Posicionamiento de las sociedades SEEN-SECO-SEEDO-SED sobre la cirugía metabólica en la diabetes mellitus tipo-2 Joint. Position Statement of the SEEN-SECO-SEEDO-SED Societies on metabolic surgery for type 2 diabetes mellitus. Endocrinol Nutr. 2013;60(10):547–8.CrossRefGoogle Scholar
  25. 25.
    Huang C, Shabbir A, Lo CH, et al. Laparoscopic Roux-en-Y gastric bypass for the treatment of type II diabetes mellitus in Chinese patients with body mass index of 25-35. Obes Surg. 2011;21:1344–9.CrossRefGoogle Scholar
  26. 26.
    Cohen R, Pinheiro JS, Correa JL, et al. Laparoscopic Roux-en-Y gastric bypass for BMI < 35 kg/m2: a tailored approach. Surg Obes Relat Dis. 2006;2:401–4.CrossRefGoogle Scholar
  27. 27.
    Lee WJ, Wang W, Lee YC, et al. Effect of laparoscopic minigastric bypass for type 2 diabetes mellitus: comparison of BMI > 35 and < 35 kg/m2. J Gastrointest Surg. 2008;12:945–52.CrossRefGoogle Scholar
  28. 28.
    Navarrete S, Leyba JL, Navarrete LLS, et al. Bypass gástrico en Y de Roux para el tratamiento de pacientes con diabetes mellitus tipo II con IMC de 30 a 35 kg/m2. Nutr Hosp. 2012;27(4):1160–5.Google Scholar
  29. 29.
    Lee WJ, Wang W. Bariatric surgery: Asia-pacific perspective. Obes Surg. 2005;15:751–7.CrossRefGoogle Scholar
  30. 30.
    Navarrete S, Leyba JL, Li SN, et al. Results of the comparative study of 200 cases: one anastomosis gastric bypass vs Roux-en y- gastric bypass. Obes Surg. 2018;28(9):2597–602.CrossRefGoogle Scholar
  31. 31.
    Kular K, Manchanda NY, Rutledge R. A 6-year experience with 1054 mini-gastric bypasses—first study from Indian subcontinent. Obes Surg. 2014;24:1430–5.CrossRefGoogle Scholar
  32. 32.
    Noun R, Skaff J, Riachi E, et al. One thousand consecutive minigastric bypass: short- and long-term outcome. Obes Surg. 2012;22:697–703.CrossRefGoogle Scholar
  33. 33.
    Navarrete S, Leyba JL, Navarrete LLS, et al. Complications of the one anastomosis gastric bypass/minigastric bypass. Myths and realities. BMI. 2018;8.3.3:2344–54.Google Scholar
  34. 34.
    Musella M, Susa A, Greco F, et al. The laparoscopic mini-gastric bypass: the Italian experience: outcomes from 974 consecutive cases in a multicenter review. Surg Endosc. 2014;28(1):156–63.CrossRefGoogle Scholar
  35. 35.
    Wang W, Wei P, Lee Y. Short-term results of laparoscopic mini-gastric bypass. Obes Surg. 2005;15:648–54.CrossRefGoogle Scholar
  36. 36.
    Kular KS, Manchanda N. Cheema GKSeven years of mini-gastric bypass in type II diabetes patients with a body mass index <35 kg/m(2). Obes Surg. 2016;26(7):1457–62.CrossRefGoogle Scholar
  37. 37.
    Kasama K, Mui W, Lee WJ, et al. IFSO-APC consensus statements 2011. Obes Surg. 2012;22(5):677–84.CrossRefGoogle Scholar
  38. 38.
    Lee WJ, Chong K, Lin YH, et al. Laparoscopic sleeve gastrectomy versus single anastomosis (mini-) gastric bypass for the treatment of type 2 diabetes mellitus: 5-year results of a randomized trial and study of incretin effect. Obes Surg. 2014;24:1552–62.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Universidad Central de VenezuelaCaracasVenezuela
  2. 2.Cleveland ClinicClevelandUSA
  3. 3.Hospital Rio HortegaValladolidSpain

Personalised recommendations